The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W., Bartunek J., KILIÇ T., ...More

EUROINTERVENTION, vol.15, no.5, pp.403-410, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 5
  • Publication Date: 2019
  • Doi Number: 10.4244/eij-d-19-00342
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.403-410
  • Keywords: atrial septal defect, chronic heart failure, clinical trials, innovation, DIASTOLIC FUNCTION, INTERATRIAL SHUNT, LAP-HF, DIAGNOSIS, PRESSURE, ECHOCARDIOGRAPHY, EXERCISE, SOCIETY, DEVICE, ADULT
  • Bezmialem Vakıf University Affiliated: Yes


Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.